9.15
Elicio Therapeutics Inc stock is traded at $9.15, with a volume of 147.23K.
It is down -1.08% in the last 24 hours and down -17.12% over the past month.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
See More
Previous Close:
$9.25
Open:
$9.27
24h Volume:
147.23K
Relative Volume:
1.41
Market Cap:
$149.50M
Revenue:
-
Net Income/Loss:
$-33.82M
P/E Ratio:
-0.3576
EPS:
-25.5891
Net Cash Flow:
$-66.04M
1W Performance:
-6.06%
1M Performance:
-17.12%
6M Performance:
+66.36%
1Y Performance:
+98.48%
Elicio Therapeutics Inc Stock (ELTX) Company Profile
Name
Elicio Therapeutics Inc
Sector
Industry
Phone
(857) 209-0050
Address
451 D STREET, 5TH FLOOR, BOSTON
Compare ELTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ELTX
Elicio Therapeutics Inc
|
9.15 | 151.13M | 0 | -33.82M | -66.04M | -25.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Elicio Therapeutics Inc Stock (ELTX) Latest News
How Elicio Therapeutics Inc. (9HA) stock reacts to new regulationsJuly 2025 Update & Technical Buy Zone Confirmation - newser.com
How high can Elicio Therapeutics Inc. stock goEarnings Recap Report & Smart Money Movement Tracker - newser.com
Can Elicio Therapeutics Inc. stock outperform in 2025 bull market2025 Volatility Report & Daily Profit Maximizing Tips - newser.com
Will Elicio Therapeutics Inc. outperform the marketMarket Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
Using economic indicators to assess Elicio Therapeutics Inc. potentialJuly 2025 Market Mood & Low Drawdown Investment Strategies - newser.com
Elicio Therapeutics Inc. stock trendline breakdown2025 Trade Ideas & AI Powered Market Entry Strategies - newser.com
Analyzing net buyer seller activity in Elicio Therapeutics Inc.Weekly Trading Summary & Safe Entry Momentum Stock Tips - newser.com
Analyzing drawdowns of Elicio Therapeutics Inc. with statistical toolsWeekly Stock Report & High Return Trade Guides - newser.com
Statistical indicators supporting Elicio Therapeutics Inc.’s strengthJuly 2025 News Drivers & Expert Approved Momentum Trade Ideas - newser.com
How Elicio Therapeutics Inc. (9HA) stock moves in volatile trading sessionsMarket Sentiment Report & Daily Volume Surge Signals - newser.com
Elicio (NASDAQ: ELTX) to present late-breaking Phase 2 ELI-002 data at SITC 2025 - Stock Titan
Key metrics from Elicio Therapeutics Inc.’s quarterly dataMarket Rally & Low Drawdown Investment Ideas - newser.com
Is Elicio Therapeutics Inc. stock oversold or undervalued2025 Volatility Report & Growth Focused Entry Point Reports - newser.com
Is Elicio Therapeutics Inc. (9HA) stock bottoming after sell offBull Run & Expert-Curated Trade Recommendations - newser.com
What valuation multiples suggest for Elicio Therapeutics Inc. stockMarket Volume Report & Safe Swing Trade Setups - newser.com
Can Elicio Therapeutics Inc. (9HA) stock attract ESG investmentsEarnings Overview Summary & Low Drawdown Momentum Trade Ideas - newser.com
Can Elicio Therapeutics Inc. stock weather global recessionQuarterly Profit Report & Daily Entry Point Trade Alerts - newser.com
Is Elicio Therapeutics Inc. stock attractive for hedge funds2025 Support & Resistance & Free Safe Capital Growth Stock Tips - newser.com
How Elicio Therapeutics Inc. stock compares to market leadersEarnings Overview Report & Fast Momentum Stock Entry Tips - newser.com
Elicio Therapeutics, Inc. (ELTX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
What earnings revisions data tells us about Elicio Therapeutics Inc.Weekly Gains Report & Capital Efficient Trade Techniques - newser.com
Is Elicio Therapeutics Inc. stock poised for growthFed Meeting & Risk Managed Investment Entry Signals - newser.com
Elicio Therapeutics Inc Stock (ELTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):